Survivin is observed uniquely in tumor cells and developmental cells, which undergo either inappropriate or programmed cell growth. In the current study, we investigated the in¯uence of Survivin on cell cycle. Overexpression of Survivin resulted in accelerated S phase shift, resistance to G1 arrest, and activated Cdk2/ Cyclin E complex leading Rb phosphorylation. In addition, nuclear translocation of Survivin followed by an interaction with Cdk4 was detected. Interestingly, Survivin nuclear translocation coincided with S phase shift, and prevention of nuclear transport suppressed Survivin nuclear translocation and S phase shift. Further, we also observed that Survivin competitively interacted with the Cdk4/p16
Introduction
Cell cycle regulation is important for understanding cellular homeostasis and carcinogenesis, and many factors have been identi®ed as cell cycle-associated factors. Cyclins and cyclin-dependent kinases (Cdks) are necessary for cell cycle progression, especially the G1 and S phase progression (Sherr and Roberts, 1995) . Various Cyclin/Cdk heterocomplexes act as essential accelerators of cell cycle progression at dierent phases of the cell cycle. Among these, the Cdk2/Cyclin E complex plays a central role for the S phase progression, since the activated Cdk2/Cyclin E complex initiates retinoblastoma protein (Rb) phosphorylation which is the direct initiator for the S phase progression during cell cycle (Buchkovich et al., 1989; Chen et al., 1989; DeCaprio et al., 1989; Lin et al., 1991; Zhu et al., 1996) .
Various cell cycle suppressors have also been identi®ed, including the Cdk or Cyclin/Cdk complex inhibitors. The INK4 family are Cdk inhibitor proteins, and four proteins (p16 INK4a , p15 INK4b , p18
INK4c and p19
INK4d
) have been identi®ed in this family (Hirai et al., 1995; Sherr and Roberts, 1995; Parry et al., 1999) . The INK4 family is unique in that the inhibitors speci®cally bind to Cdk4 and its homolog Cdk6, which are kinases responsible for the ®rst wave of Cdk activity during the cell cycle (Hirai et al., 1995; Sherr and Roberts, 1995; Reynisdottir and Massague, 1997; Parry et al., 1999) . Another type of cell cycle suppressor, the WAF1/Kip1 family members, suppress Cyclin/Cdk complex activity. p21 WAF1 (Harper et al., 1993; Li et al., 1994) interacts with the Cyclin D/Cdk4 complex and the p27 Kip1 homolog (Polyak et al., 1994) suppresses the Cyclin E/Cdk2 complex (Sherr and Roberts, 1995; Reynisdottir and Massague, 1997; Albrecht et al., 1998) . Thus, the cell cycle progression from G1 phase to S phase is initiated by phosphorylated Rb, which is regulated by Cyclin/Cdk complexes and multiple suppressor proteins.
Cell death is also an important phenomenon for cellular homeostasis as well as cell proliferation, and is observed during physiological cell death, disease states and embryonic development (Wyllie et al., 1980; Buttyan et al., 1989; Nagata, 1994; Nagata and Golstein, 1995; Suzuki et al., 1996) . A variety of cell death-associated factors have been identi®ed. Caspase refers to the cysteine proteinase family which acts as the death mediator during the intracellular cell death signaling (Alnemri et al., 1996) . Caspase activation is regulated by various proteins, including the inhibitory proteins of the IAP family.
Survivin is a recently identi®ed IAP family protein (Ambrosini et al., 1997) , and its expression is detected speci®cally in tumor cells (Adida et al., 1998a; Kawasaki et al., 1998; Lu et al., 1998; Swana et al., 1999) and in cells during embryonic development (Adida et al., 1998b) . Compared with other IAP family members, such as crmA, p35, iap and ILP (Clem and Miller, 1994; Gagliardini et al., 1994; Miura et al., 1995; Xue and Horvitz, 1995; Duckett et al., 1996; Deveraux et al., 1997) , Survivin contains a single baculovirus IAP repeat, lacks a carboxyl-terminal RING ®nger and is unique in that its expression is observed only in proliferating cells. Thus, possible involvement of Survivin in cell proliferation is suggested , however, the molecular details are not understood. In the current study, therefore, we investigated the in¯uence of Survivin on cell cycle progression. Here, we report that Survivin competitively binds with the Cdk4/p16
Results

Death suppression by Survivin is weaker than ILP
Human hepatoma SK-Hep1 cells were microinjected with GST, GST-Survivin or GST-ILP, followed by 24 h co-treatment with agonistic Fas antibody (CH-11 clone, Yonehara et al., 1989) and de novo protein synthesis inhibitor (transcriptional inhibitor) actinomycin D, similar to human hepatoma HepG2 cells (Suzuki et al., 1998 (Suzuki et al., , 1999a . Microinjection with GST-ILP resulted in complete prevention of Fasmediated cell death, while the death suppression ability of Survivin was weaker than GST-ILP (Figure 1 ). In the current study, same results were observed using puri®ed ILP and Survivin from HepG2 cells (data not shown).
Cell cycle association of Survivin
Since speci®c expression of Survivin has been detected in proliferating cells, we investigated whether overexpression of Survivin in¯uences cell cycle. We prepared some Survivin overexpressing cell lines: pcDNA3.1-B-Survivin-transfected SK-Hep1 (SK-SA7/ SC2/SE8/SJ3/SZ4) and sham-transfected SK-Hep1 (SK-VE2). As shown in Figure 2a , SK-VE2 cells showed endogenous expression of Survivin and overexpression of Survivin was detected in the other cells. Among Survivin-transfected cell lines, SK-SA7 cells showed the most intense expression of Survivin, therefore, SK-SA7 cells were used for the further experiments.
Using these cell lines, cell cycle analysis bȳ owcytometry revealed cells overexpressing Survivin had an increased S phase population and a decreased G1 phase population (Figure 2b ). No changes in the G2/M phase population was observed (Figure 2b ). Increased S phase population was detected in other Survivin-transfected cells (data not shown). In addition, we also observed resistance to G1 arrest in SK-SA7 cells. When cells were cultured in serum freemedia for 48 h, the S phase population of SK-VE2 cells was decreased, however, that of SK-SA7 cells did not change signi®cantly (Figure 2c ). Cell growth activity of SK-SA7 cells was higher than SK-VE2 cells, and SK-SA7 cells showed an increase in cell number even in the serum free media (Figure 2d ).
For additional evaluation of Survivin in the cell cycle entry, G2/M phase population was measured under the presence of colchicine. As shown in Figure 2e , an accumulation of G2/M phase population was accelerated in the SK-SA7 cells.
Phosphorylation of Rb
The above results suggest the possibility that Survivin initiates S phase entry, which may involve phosphorylation of Rb, the direct inducer of S phase initiation (Buchkovich et al., 1989; Chen et al., 1989; DeCaprio et al., 1989; Lin et al., 1991; Zhu et al., 1996) . Immunoblotting analysis of SK-SA7 cells revealed an increased phosphorylation of Rb (Ser249/Ser252; Thr373; Ser780; Ser795; Ser807/Ser811 and Figure  3a ). In addition, when cells were cultured in serum free media for 48 h, SK-SA7 cells showed phosphorylation of Rb even in the serum free media (Figure 3b) , demonstrating resistance to G1 arrest in the SK-SA7 cells.
Nuclear translocation of Survivin during cell cycle
The subcellular localization of Survivin was investigated by immunoblotting of fractionated proteins. Survivin expression was observed in both the cytoplasmic and nuclear fractions, however, there were some dierences observed between the SK-VE2 and SK-SA7 cells. In SK-VE2 cells, Survivin expression was detected predominantly in the cytoplasmic fraction, whereas, SK-SA7 cells localized Survivin predominantly in the nucleus (Figure 4a ). This result raised the possibility that Survivin is translocated to the nucleus during cell cycle. To investigate Survivin subcellular localization during S phase progression from G1 arrest, SK-VE2 cells were arrested at the G1 phase by serum free culture. Under these conditions, the amount of cytoplasmic Survivin was increased, whereas, subsequent culture in conditioned medium initiated an increase in the amount of nuclear Survivin (Figure 4b ).
Survivin interacts with Cdk4
The current results suggested the involvement of Survivin in cell cycle progression, especially S phase progression. Therefore, we investigated whether Survivin interacts with cell cycle-associated factor(s) using co-immunoprecipitation analysis. As shown in Figure  5 , Survivin interacted only with Cdk4 among the various factors tested (Cdk2, Cdk4, Cyclin D1, Cyclin E, p21 WAF1 and p27
Kip1
).
Influence of Survivin in Cyclin/Cdk complexes
To further investigate the in¯uence of Survivin in cell cycle progression, we compared Cyclin/Cdk complexes between SK-VE2 and SK-SA7 cells. When Cdk2 immunoprecipitates were incubated with the antibody for Cyclin E or p27
Kip1
, the Cyclin E interaction with Cdk2 did not show any changes between SK-VE2 and SK-SA7 cells. However, SK-SA7 cells showed a decrease in the amount of p27
Kip1 that interacted with Cdk2 ( Figure 6 ). In parallel experiments, Cyclin D1 immunoprecipitates were also incubated with the . Cdk4 antigen expression did not show any dierences between the cell lines, however, a decrease in p21 WAF1 antigen and an increase in p27
Kip1 antigen was detected in the SK-SA7 cells ( Figure 6 ). In the current study, kinase assay for Cdk2/Cyclin E and Cdk4/Cyclin D1 was also performed. SA7 cell extracts showed Cdk2/Cyclin E activation, but VE2 cell extracts did not. In contrast, cell extracts from both SA7 and VE2 showed Cdk4/ Cyclin D1 activity ( Figure 6 ).
Effect of Survivin neutralization on the cell cycle
We investigated possible eects of Survivin neutralization by microinjection with anti-Survivin antibody. When the antibody for Survivin or rabbit IgG was microinjected into SK-VE2 or SK-SA7 cells, the amount of nuclear Survivin and S phase population in each cell was decreased signi®cantly (Figure 7a,b) . As shown above, overexpression of Survivin induced a decrease in the amount of p27
Kip1 which interacted with Cdk2. However, a functional loss of Survivin induced an increase in the Cdk2-interaction with p27
Kip1 ( Figure  7c ). We also observed that Survivin neutralization decreased Cdk2/Cyclin E kinase activity ( Figure 7c ).
Competitive interaction of Survivin with Cdk4/p16
INK4a complex
In non-tumor cells, Cdk4 is inactivated by p16
INK4a (Hirai et al., 1995; Sherr and Roberts, 1995; Parry et al., 1999) . Since a direct interaction between Survivin and Cdk4 was observed, we investigated eects of Survivin on the Cdk4/p16
INK4a and Cdk4/Cyclin D1 complexes in a cell free system. When Cdk4 immunoprecipitates were reacted with antibody for p16
INK4a or Survivin using puri®ed components, Cdk4-interacted p16
INK4a was decreased in the dose dependent manner of Survivin (®xed p16 INK4a and changed Survivin: Figure 8a ). We also observed the contrary result when Cdk4 was reacted with ®xed amount of Survivin and changed amount of p16 INK4a (Figure 8a ). Thus, p16
INK4a was completely removed by Survivin from Cdk4, suggesting that an interactive activity of Cdk4 with Survivin is intense as compared with p16
INK4a
. In contrast, Cdk4 showed the more intense interaction with Cyclin D1 than Survivin (Figure 8a ). Even in the presence of maximum level of Survivin, Cdk4 showed the interaction with Cyclin D1. In the current study, GST did not show the interaction with Cdk4 (data not shown).
In addition, we also examined whether Survivin physiologically interacts with Cdk4/p16
INK4a complex. SK-Hep1 cells do not express p16 shown). When the expression of p16
INK4a was more intense that Survivin, cell proliferation was not detected (Figure 8b ). However, cells expressing more Survivin than p16
INK4a showed cell proliferation ( Figure  8b ). We also observed that decreased amount of Cdk4/ Cyclin D1 complex, and down-regulated Cdk2/Cyclin E and Cdk4/Cyclin D1 complex activities when the expression of p16
INK4a was more intense than Survivin (Figure 8b ). These results suggest that Survivin suppressed the cell cycle arrest ability of p16
.
Discussion
Caspase is an interleukin 1b-converting enzyme (ICE)/ CED-3 homolog cysteine proteinase (Alnemri et al., 1996) that plays a central role in cell death signaling (Nagata, 1997) . Recently, cellular and viral proteins have been identi®ed that directly inhibit caspase and are referred to as the IAP family (for review, LaCasse et al., 1998) . Survivin is also a member of the IAP family, and it is unique in that its expression is encountered in only dividing cells, such as tumor cells and developing cells (Ambrosini et al., 1997; Adida et al., 1998a,b; Kawasaki et al., 1998; Lu et al., 1998; Swana et al., 1999) . As an IAP family member, Survivin contains a single baculovirus IAP repeat (Ambrosini et al., 1997) and interacts directly with caspase 3 (CPP32/Yama/Apopain) and 7 (Mch3, ICE-LAP3, CMH-1) in a cell free system (Tamm et al., 1998) . The speci®c expression of Survivin in dividing cells and the inhibition of cell proliferation by gene targeting suggest the possible involvement of Survivin in cell cycle progression. In the current study, we investigated the in¯uence of Survivin on cell cycle progression. Initial studies investigated the death suppression ability of Survivin. Human hepatoma SK-Hep1 cells endogenously express Fas, which is the death suppressor that transduces cell death signaling upon stimulation by Fas ligand (Nagata, 1994; Nagata and Golstein, 1995) , on their cell surface (data not shown). Survivin expression was well documented in various Fas expressing tumor cell lines, including SKHep1 hepatoma cell line. However, SK-Hep1 cell showed the most weak expression of Survivin among tested Fas-expressing tumor cell lines (data not shown), therefore, we used SK-Hep1 cells in our current study. When GST-Survivin was microinjected into SK-Hep1 cells, followed by the co-treatment with agonistic Fas antibody and actinomycin D, the cells still showed Fas-mediated cell death unlike the complete death suppression detected in cells microinjected with GST-ILP. This is consistent with a previous study showing that the death suppression ability of Survivin is weaker than other IAP family members (Tamm et al., 1998) . In addition, Survivin lacks a carboxyl-terminal RING ®nger (Ambrosini et al., 1997) . These reports and the current results support the possibility that Survivin may be involved with cell proliferation rather than cell death suppression.
We prepared a stable SK-SA7 cell line that overexpressed Survivin and a sham-transfected SK-VE2 for analysis of cell cycle progression. In the current study, we prepared some Survivin-expressing stable lines. Since SK-SA7 showed the most intense expression of Survivin, we used this line for the detail investigation. Some results observed in the current study were represented in all prepared cell lines, and the results were depended on the amount of Survivin (data not shown). Our current results revealed an increased population in the S phases as a result of Survivin overexpression. We suggest that cell cycle progression is directly initiated by overexpressed Survivin, but not as a result of clone recovery, since various cell lines showed high growth activity and increased S phase population when cells were transiently expressed Survivin Ito et al., 2000) . Further, G2/M phase accumulation in the presence of colchicine was accelerated in Survivin-overexpressing cells. These results suggest the accelerated cell cycle entry by Survivin. In addition, SK-SA7 cell showed an increase in cell number even in the absence of serum. These results strongly suggest that Survivin is closely involved with cell cycle progression. Speci®c expression of Survivin in the G2/M phase has been reported ). In the current study, however, we observed that both S and G2/M phase populations were increased in cells that overexpressed Survivin. In addition, we detected ubiquitous expression of Survivin during the cell cycle and its subcellular localization changed during the cell cycle. Therefore, we suggest that Survivin is involved with only the S phase, or both S and G2/M phase progression.
To investigate the molecular basis for Survivin eects during S phase initiation, we investigated the in¯uences of Survivin on cell cycle associated factors. S phase progression from the G1 phase is initiated directly by the phosphorylation of Rb at the down stream portion (Buchkovich et al., 1989; Chen et al., 1989; DeCaprio et al., 1989; Lin et al., 1991; Zhu et al., 1996) as a result of Cdk2/Cyclin E activation (Reynisdottir and Massague, 1997) . The Cdk2/Cyclin E complex is inactivated by a direct interaction with p27 Kip1 , and the Cdk4/Cyclin D1 complex activates Cdk2/Cyclin E by the removal of p27
Kip1 as a result of a direct binding event (Reynisdottir and Massague, 1997) . When cells overexpressed Survivin, an increase in the amount of phosphorylated Rb and activated Cdk2/Cyclin E complex was detected and a direct interaction between Survivin and Cdk4 was demonstrated. In contrast, there were no dierences in Cdk4/ Cyclin D1 activity. Since immunoprecipitates of Cyclin D1 did not react with Survivin antibody, we suggest that Survivin interacts with Cdk4, but not with the Cdk4/Cyclin D1 complex. Furthermore, a functional loss of Survivin induced a decrease in phosphorylated Rb (data not shown) as well as decreased free Cdk2/ Cyclin E complex and S phase population. Therefore, our current study strongly suggests that an interaction of Survivin with Cdk4 initiate S phase entry as a result of Cdk2/Cyclin E-induced phosphorylation of Rb. In the current study, we demonstrated Rb phosphorylation with its phospho-speci®c antibody at various phosphorylation site. We used Rb phosphorylation as the marker of S phase entry or the substrate for Cdk/ Cyclin kinase activity and phosphorylated Rb was detected with the same phospho-speci®c antibodies. In each experiment, all phospho-speci®c antibody showed the Rb phosphorylation (data not shown), however, we presented Rb phosphorylation with antibody for pRb at 807/811 as the typical example.
Both the INK4 and WAF1/Kip1 families are known as suppressors for the Cdk and Cyclin families and show distinct processes to arrest the cell cycle (Sherr and Roberts, 1995) . However, recent investigation revealed that the WAF1/Kip1 family members (p21 WAF1 and p27 Kip1 ) act as the stabilizer of Cdk/ Cyclin complex (Cheng et al., 1999; Sherr and Roberts, 1999) . In contrast, INK4 family members act only as suppressors for cell cycle progression Roberts, 1995, 1999; Reynisdottir and Massague, 1997) . p16
INK4a is known as a speci®c suppressor for Cdk4 and its homolog Cdk6 (Byeon et al., 1998; Parry et al., 1999; Stein et al., 1999) . Since we demonstrated that Survivin interacts with Cdk4 during the cell cycle, we investigated whether Survivin in¯uences the Cdk4/p16
INK4a complex. The current results showed a competitive interaction of Survivin with Cdk4/p16
INK4a complex to progress the cell cycle. In addition, cell cycle arrest and Cdk2/4 inactivation by transient expression of p16
INK4a was not observed in the presence of overexpressed Survivin. These results form the basis of our working model in which Survivin interacts with Cdk4 to remove p16
INK4a from the Cdk4/p16
INK4a complex, Figure 6 Eect of Survivin in Cyclin/Cdk complexes. Cdk2/Cyclin E complex phosphorylates Rb to progress into S phase and is inactivated by the interaction with p27 Kip1 (upper model Reynisdottir and Massague, 1997) . Immunoprecipitates with antibody for Cdk2 from SK-VE2 (VE2) and SK-SA7 (SA7) cells were separated by SDS ± PAGE, followed by immunobotting with antibody for Cyclin E or p27 Kip1 . Immunoprecipitates with Cyclin E antibody were also prepared for Cdk2 kinase assay. Immunoprecipitates were reacted with recombinant Rb in the kinase assay buer, and phosphorylated Rb (pRb: S807/S811) was detected. Immunoprecipitates with antibody for Cyclin D1 from SK-VE2 and SK-SA7 cells were separated by SDS ± PAGE, followed by immunoblotting with antibody for Cdk4, p21 WAF1 or p27
Kip1
. Immunoprecipitates with Cyclin D1 antibody were also used for Cdk4 kinase assay which was also measured as Rb phosphorylation which then induces G1 phase arrest and initiates G1-progression as a result of an interaction with Cdk4. Interestingly, we demonstrated additionally that the interaction of Cdk4 with Cyclin D1 was more intense than Survivin. Cell cycle initiation and cell growth were triggered by Survivin nuclear translocation. Therefore, we suggest that Survivin remove p16
INK4a from Cdk4 to transport Cdk4 into nuclei and Survivin/Cdk4 complex which translocates into nuclei, was replaced by Cdk4/Cyclin D1 complex by more intense interaction of Cyclin D1.
Survivin was identi®ed originally as an IAP family member (Ambrosini et al., 1997) which acts as a death suppressor as a result of caspase suppression (Clem and Miller, 1994; Duckett et al., 1996; Deveraux et al., 1997; LaCasse et al., 1998) . Survivin is unique in that its expression is detected speci®cally in dividing cells, including various tumor cells (Ambrosini et al., 1997; Adida et al., 1998a,b; Lu et al., 1998; Li and Altieri, 1999) . These observations led us to the possibility that Survivin may participate in cell cycle entry. An interesting result from the Survivin gene targeting experiment revealed a possible involvement of Survivin in cell proliferation, however, the molecular mechanisms for this has not been clari®ed yet. In the present study, we demonstrated that Survivin competitively interacted with the Cdk4/ p16 . However, Survivin expression (transcription and translation) is induced upon cell growth stimulation, including oncogenic stimulation. Induced Survivin competitively interacts with Cdk4 to remove p16 INK4a from the complex, and the resultant Cdk4/Survivin complex activate directly or indirectly the Cdk2/Cyclin E complex. Thus, the activated Cdk2/Cyclin E complex phosphorylates Rb for the S phase progression. We also propose here that the speci®c expression of Survivin in various tumor cells is the cause for carcinogenesis, rather than a result of carcinogenesis. Recently, p34SEI-1 was reported as the Cdk4 activator, and it appears to antagonize the function of p16
INK4a (Sugimoto et al., 1999) . The physiological role of Survivin which we demonstrated in the current study, is close similar to p34SEI-1. We suggest that multiple intricate systems are involved with cell cycle progression, and the new expression of Survivin is a key element for cell cycle progression.
Materials and methods
Cell line and culture
Human hepatoma SK-Hep1, SK-VE2 (vector transfected clone) and SK-SA7 (Survivin overexpression clone) cells were maintained in Dulbecco's Modi®ed Eagle Medium (DMEM: Gibco BRL, MD, USA) supplemented with 10% heatinactivated fetal bovine serum (FBS; HyClone Laboratories Immunoprecipitates with antibody for Cdk2 from cells treated as in (a) were separated by SDS ± PAGE, followed by immunoblotting with p27 Kip1 . From each treated cells, immunoprecipitates with Cyclin E antibody were also prepared for Cdk2 kinase assay Inc., UT, USA) and 1% non-essential amino acids (NEAA: Cosmo Bio., Tokyo, Japan) in a humidi®ed atmosphere of 5% CO 2 and 95% air.
Preparation of fractionated proteins
Cells were collected and washed with ice-cold PBS, and then suspended in buer I (2 mM EDTA, 10 mM Tris-HCl, pH 7.5). After incubation on ice for 10 min, an equal volume of buer II (0.5 M sucrose, 0.1 M KCl, 10 mM MgCl 2 , 2 mM CaCl 2 , 2 mM EDTA, 10 mM Tris-HCl, pH 7.5) was added. The nuclear-rich fraction was pelleted by centrifugation (2700 r.p.m./10 min). The supernatant was removed to a separate tube and again centrifuged (43 000 r.p.m./90 min).
The supernatant was collected as the cytosol-rich fraction, and the pellet was dissolved in buer III (8 mM CHAPS, 150 mM NaCl, 0.1 M sucrose, 2 mM EDTA, 10 mM Tris-HCl, pH 7.5) and incubated at 48C for 2 h. The membrane-rich fraction was then collected by centrifugation (43 000 r.p.m./ 60 min).
Immunoblotting analysis
Sample proteins separated by SDS ± PAGE were transferred onto nitrocellulose membranes with a semi-dry blotting system. The membranes were blocked with PBS containing 5% (w/v) skim milk at room temperature for 1 h, washed with a mixture of PBS and 0.05% Tween 20 (Sigma, Tween- Figure 8 Competitive interaction between Survivin, p16
INK4a and Cyclin D1 for Cdk4. (a) Puri®ed human Cdk4 from HepG2 cells (10 mM) was mixed with INK4a and GST-Survivin, or GST-Cyclin D1 and GST-Survivin. In this experiment, the reaction of each factor with Cdk4 was performed with ®xed amount (10 mM) or changed amount (0, 2.5, 5 or 10 mM). Cdk4 was immunoprecipitated, followed by immunoblotting with antibody for p16 PBS), and then incubated overnight at room temperature with each antibody diluted with PBS. After washing with Tween-PBS, the membranes were incubated with a 1000-fold diluted biotinylated anti IgG antibody (Bio Source, CA, USA), washed with Tween-PBS, and then incubated with avidin-HRP (Vector Lab., CA, USA) at room temperature for 1 h. The membranes were washed with Tween-PBS and then developed with the ECL system.
Immunoprecipitation analysis
Each antibody was mixed with 1 mg protein from each cell extract for 30 min. After mixing, protein A-sepharose was added and incubated for 2 h. The immunoprecipitates were heated in SDS sample buer and separated on 5 ± 20% polyacrylamide gels. After transfer, the membranes were immunoblotted, washed with Tween-PBS and developed using the ECL system (Amersham, Buckinghamshire, UK).
Cell cycle analysis
Cell cycle distribution was determined by measuring the cellular DNA content using¯owcytometry. Brie¯y, 1610 6 cells were collected and ®xed with 70% ice-cold ethanol. RNaseA (10 mg/ml) was added and the cells were incubated for 30 min at 378C. The cells were resuspended in 0.5 ml propidium iodide solution (50 mg/ml in 0.1% sodium citrate with 0.1% NP-40). Propidium iodide stained cells were analysed with a FACScan cytometer using CellQuest software (Becton Dickinson, Tokyo, Japan).
Preparation of Survivin antibody
A polyclonal antibody to Survivin was generated in rabbits using a synthetic peptide (A3PTLPPAWQPFLKDHRI19C) and puri®ed by anity chromatography on a peptideSepharose matrix (5 mg/ml peptide) with elution of speci®c IgG in 1 mol/l glycine, pH 2.5.
Preparation of GST-Survivin and Survivin expression vector
The cDNA was ampli®ed using RT ± PCR from total RNA of SW480 colorectal cancer cell line. The 5'-sense primer and the 3'-antisense primer were 5'-CCGGGATCCATGGG-TGCCCCGACGTTG-3' and 5'-CGCGAATTCAGAGGC-CTCAATCCATGG-3', respectively. The ampli®ed fragments were ®rst subcloned into the pCR2.1 vector. The cloned cDNA was excised by digestion with BamHI and EcoRI and ligated into the pGEX 4T-1 vector (for preparation of GSTSurvivin) or pcDNA3.1-B vector (for the preparation of expression vector). The three constructs were used to transform competent Escherichia coli BL21 (DE3) cells and cultured on Luria-Bertani (LB) plates at 378C for 12 h. Single colony cultures were grown at 378C until the OD600 nm reached 0.6 ± 0.8, induced with isopropyl1-thio-5'-D-galactoside (0.1 mM) and the cultures grown for an additional 4 h. The cell pellets were homogenized and sonicated. After centrifugation, the supernatants were clari®ed by ®ltration through a 0.45 mm ®lter, and soluble GST fusion proteins were puri®ed from the supernatant by anity chromatography on glutathione-Sepharose.
Preparation of Survivin overexpressed cell line
Transfection was performed with TRANSFECTAM (WAKO Pure Chemical, Osaka, Japan) with control cells receiving only plasmid pcDNA3.1-LacZ. Cells overexpressing Survivin were selected with G418-containing conditioned medium after the transfection. Selected colonies were cultured and the expression level of Survivin in each colony was measured by immunoblotting analysis.
Microinjection procedure
Proteins were diluted in PBS to 1 mg/ml and microinjection of cells (about 5000 ± 10 000 cells/plate) was performed with a Eppendorf Transjector 5246. Microinjection was performed at 100 hPa for 3 s. In the present study, no abnormalities were observed during the ®rst week after the cells were microinjected with PBS. Cells were seeded on coated plastic plate (Eppendorf), and injected cells were separated from non-injected cells by removal of the plate. Injected cells were separated from plates with trypsin and protein extraction for immunoblotting or protein kinase assays or S phase determination (Cell Cycle Test Kit with Flowcytometry: 5000 cell count) were performed from cells seeded on 2 ± 3 plates for each experiment.
